The aim of the current study was to evaluate a newly developed electrochemiluminescence (ECL)-GAD antibody (GADA) assay and compare its sensitivity and disease relevance with standard radioassay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback